Trials / Completed
CompletedNCT03448445
A Study to Evaluate Alzheimer's Disease Conversion Rate Differences Between High-risk Mild Cognitive Impairment (MCI) and Low-risk MCI in a Real World Setting
An Observational Study to Evaluate AD Conversion Rate Differences Between High-risk MCI and Low Risk MCI in Real World Setting
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 201 (actual)
- Sponsor
- Eisai Korea Inc. · Industry
- Sex
- All
- Age
- 55 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
This study will be conducted to evaluate the rate of Alzheimer's disease conversion differences between high-risk mild cognitive impairment (MCI) and low-risk MCI.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Usual care setting | usual care settings without any intervention |
Timeline
- Start date
- 2018-06-22
- Primary completion
- 2021-08-10
- Completion
- 2021-08-10
- First posted
- 2018-02-28
- Last updated
- 2021-10-06
Locations
16 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03448445. Inclusion in this directory is not an endorsement.